"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"

NCT03241901 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

DRUG: Artemether-Lumefantrine Tab 20-120mg
DRUG: Primaquine Phosphate 0.25 mg/kg
OTHER: Placebo

Sponsor

Muhimbili University of Health and Allied Sciences

Collaborators

[object Object]
[object Object]
[object Object]